Outcome of Patients With Lung Masses Who Are Treated With Radiofrequency Ablation (RFA)
Completed
Conditions studied: Non-small Cell Lung Cancer (NSCLC)
In brief
We are collecting clinical notes and results of imaging studies (CT and PET scans) from referring physicians who follow the clinical status of patients treated with radiofrequency ablation (RFA). The research objective is to determine whether the patients with (RFA) remain alive, and whether they are in remission or have progressive/ recurrent malignancy
Key facts
- Study ID
- NCT00641238
- Run by
- State University of New York - Upstate Medical University
- People needed
- 20
- Starts
- 2004-03-01
- Expected to finish
- 2011-02-01
- Last updated by the study team
- 2023-12-15
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients with lung masses
- Patients who consent to radiofrequency ablation of mass
Where it is running
- Upstate Medical University — Syracuse, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.